TRPV2 and hepatocellular carcinoma: Over-expression of TRPV2 in H2O2-treated hepatocellular carcinoma cells exacerbated the inhibition of AKT and Nrf2, whereas the activation of p38 and JNK has been enhanced at the early stage of cell death.